Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

Ver­tex Phar­ma­ceu­ti­cals an­nounced high­ly an­tic­i­pat­ed re­sults from a Phase 2 tri­al Thurs­day morn­ing in a chron­ic pain con­di­tion, say­ing its non …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.